Resolving unreported conflicts of interest

JAMA

Volumn 302, Issue 2, 2009, Pages 198-199

  DeAngelis, Catherine D ^a   Fontanarosa, Phil B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTHOR; CONFIDENTIALITY; CONFLICT OF INTEREST; DECISION MAKING; EDITORIAL; ETHICS; FINANCIAL MANAGEMENT; INTERPERSONAL COMMUNICATION; MEDICAL LITERATURE; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; TRUST; PUBLISHING;

CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES;

EID: 67650115764     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.302.2.198     Document Type: Editorial

References (13)

1. Harris G. Top psychiatrist didn't report drug makers' pay. New York Times. October 3, 2008.
2. Giles J. Exposing the links between doctors and big pharma. New Scientist. February 2009.
3. Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
4. AAMC. Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research. https://services.aamc.org/Publications/showfile.cfm?file=version107. pdf&prd-id=220&prv-id=268&pdf-id=107. February 2008. Accessed March 20, 2009.
5. Steinbrook R. On-line disclosure of physician-industry relationships. N Engl J Med. 2009;360(4):325-327.
6. Robinson RG, Arndt S. Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression. JAMA. 2009;301(10):1023-1024.
7. Ridker PM. Incomplete financial disclosure for study of funding and outcomes in major cardiovascular trials. JAMA. 2006;295(23):2725-2726.
8. Natanson C. Incomplete financial disclosure in a study of cell-free hemoglobin-based blood substitutes and risks of myocardial infarction and death. JAMA. 2008;300(11):1300.
9. Yao GL, Albertson P, Shih W, Yao SL. Failure to report financial disclosure information. JAMA. 2009;301(1):35-36.
10. DeAngelis CD, Fontanarosa PB. Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial [published online April 20, 2009]. JAMA. 2008;299(14):1669-1677. JAMA. 2009;301(18):1931. doi:10.1001/jama.2009.640.
11. Flanagin A, Fontanarosa PB, DeAngelis CD. Update on JAMA's conflict of interest policy. JAMA. 2006;296(2):220-221.
12. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294(1):110-111.
13. DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. 2008;299(15):1833-1835.